Carol Langford, M.D., MHS, FACP

Carol A. Langford, MD, MHS, FACP, received her medical degree at the University of California Los Angeles in 1987 and trained in internal medicine at the University of Michigan from 1987 to 1990. She was a fellow in rheumatology at Duke University Medical Center from 1990 to 1994. In 1995, she received a Master's Degree in health sciences from Duke University in order to pursue a career in clinical investigation.

From 1994 to 2004, Dr. Langford was a senior investigator within the Immunologic Diseases Section of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). At the NIH, Dr. Langford’s research focused on vasculitic diseases, where she was Principal Investigator for nine vasculitis-related protocols. From 1999 to 2002, Dr. Langford served as Chairman of the NIAID Institutional Review Board in supporting the protection of human subjects. While at the NIH, Dr. Langford received an NIAID Special Act of Service Award in 2001 and was the recipient of NIAID Staff Recognition Awards from 1998 through 2004.

In 2004, Dr. Langford joined the Cleveland Clinic to become Director of the Center for Vasculitis Care and Research within the Department of Rheumatic and Immunologic Diseases. She is an Associate Professor of Medicine of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and was named Vice-Chair of Rheumatology for Research in 2007.

At the Cleveland Clinic, Dr. Langford’s work has continued to focus on patient care and research in vasculitic diseases, including Wegener’s granulomatosis, giant cell arteritis, Takayasu’s arteritis, polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and other forms of vasculitis. In 2007, she was awarded an important research contract from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH for concurrent pilot studies in giant cell arteritis and Takayasu’s arteritis. She has additionally received funding from the Rare Diseases Clinical Research Network of the NIH to conduct studies in Wegener’s granulomatosis. These studies will be conducted in partnership with colleagues in the Vasculitis Clinical Research Consortium, a collaborative research network funded by the NIH.

Dr. Langford is an active member of the American College of Rheumatology, where she has served on several committees. She was an Associate Editor for Arthritis and Rheumatism, a leading journal in rheumatology, from 2000 to 2005. Dr. Langford serves as a consultant to the Vasculitis Foundation. For the last two years, she has been named one of Cleveland’s Top Doctors by Cleveland magazine.

A frequently invited lecturer at national and international medical meetings, Dr. Langford has authored more than 50 scientific papers and chapters on vasculitis. She is Co-Editor with Anthony Fauci, MD, for Harrison’s Rheumatology taken from Harrisons’s Principles of Internal Medicine.

• Research Contract Award, NIAMS, National Institutes of Health, 2007-2012, Principal Investigator for a study entitled “Concurrent Pilot Studies in Giant Cell Arteritis (GCA) and Takayasu’s arteritis (TAK) to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis.”
• Director, Center for Vasculitis Care and Research, Cleveland Clinic, 2004-Present
• Vice-Chair, Rheumatology for Research, Cleveland Clinic, 2007-Present
• Senior Investigator, NIAID, National Institutes of Health, 1994-2004
• Chair, Institutional Review Board, NIAID, National Institutes of Health, 1999-2002

• Master of Health Sciences, Duke University, 1995

Rheumatology

Internal Medicine

• Research funding, Principal Investigator NIH/NIAMS Contract Award, 2007-2012
• Top Docs in Cleveland, Cleveland magazine, 2006-2007
• NIAID Staff Recognition Award, 1998-2004
• NIAID Special Act of Service Award, 2001
• UCLA Honors in Internal Medicine, 1987
• Phi Beta Kappa, 1984   

• American College of Physicians
• American College of Rheumatology